Dipeptidyl peptidase-IV inhibitors are efficient adjunct therapy in HNF1A maturity-onset diabetes of the young patients--report of two cases.
Autor: | Katra B, Klupa T, Skupien J, Szopa M, Nowak N, Borowiec M, Kozek E, Malecki MT |
---|---|
Zdroj: | Diabetes Technology & Therapeutics; Apr2010, Vol. 12 Issue 4, p313-316, 4p |
Databáze: | Complementary Index |
Externí odkaz: |